NASDAQ: IMAImagenebio Inc Stock Ownership - Who owns Imagenebio?
Insider buying vs selling
Have Imagenebio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jotin Marango | Chief Financial Officer | 2025-07-28 | 4,630 | $17.16 | $79.45kSell |
| David P. Bonita | Director | 2025-07-25 | 83,611 | $29.90 | $2.50MBuy |
| Orbimed Advisors LLC | Director | 2025-07-25 | 83,611 | $2.49 | $208.19kBuy |
| Otello Stampacchia | Director | 2025-07-25 | 267,556 | $29.90 | $8.00MBuy |
IMA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IMA insiders and whales buy or sell their stock.
IMA Shareholders
What type of owners hold Imagenebio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jean Francois Formela | 25.95% | 2,901,609 | $18.77M | Insider |
| Otello Stampacchia | 24.19% | 2,704,484 | $17.50M | Insider |
| Atlas Venture Fund XI LP | 18.93% | 2,116,569 | $13.69M | Insider |
| Jonathan Jian Wang | 9.97% | 1,115,005 | $7.21M | Insider |
| Deep Track Capital LP | 7.86% | 878,516 | $5.68M | Institution |
| Bvf Inc | 7.17% | 802,102 | $5.19M | Institution |
| Atlas Venture Fund X LP | 6.70% | 749,634 | $4.85M | Insider |
| Blue Owl Capital Holdings LP | 4.84% | 540,924 | $3.50M | Institution |
| Omega Fund Management LLC | 4.07% | 455,361 | $2.95M | Institution |
| Orbimed Advisors LLC | 3.39% | 378,556 | $2.45M | Institution |
IMA vs Biotech Stocks
Imagenebio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.